期刊文献+

对卵巢浆液性癌的新认识 被引量:8

下载PDF
导出
摘要 近年研究表明卵巢浆液性癌为异源性,存在二元发生模式,其起源、遗传学改变、组织形态和生物学行为均有很大不同,分别被称之为低级别与高级别浆液性癌。卵巢低级别浆液性癌属于Ⅰ型癌,来自交界性肿瘤,主要表现为微乳头形态与KRAS和BRAF基因的突变,肿瘤呈渐进性发展,惰性病程。高级别浆液性癌属于Ⅱ型癌,细胞显著异型,多有TP53突变,卵巢自身见不到前驱病变,呈高度侵袭性病程,多数来自输卵管伞端早期浆液性病变的扩散。
出处 《诊断病理学杂志》 CSCD 2011年第4期308-310,共3页 Chinese Journal of Diagnostic Pathology
  • 相关文献

参考文献7

  • 1Smith Sehdev AE, Sehdev PS, Kunnan RJ. Noninvasive and invasive micropapillary (low-grade) serous carcinoma of the ovary:a clinicopathologic analysis of 135 cases [ J]. Am J Surg Pathol, 2003,27(6) :725 -736.
  • 2Roh MH, Kindelberger D, Crum CP. Serous tubal intraepithelial carcinoma and the dominant ovarian mass: clues to serous tumor origin[J] ? Am J Surg Pathol, 2009,33(3) :376 -383.
  • 3Silva EG, Deavers MT, Malpica A. Patterns of low-grade serous carcinoma with emphasis on the nonepithelial-lined spasces pattern of invasion and the disoiganized orphan papillae[ J ]. Int J Gynecol Pathol,2010,29:507 - 512.
  • 4Dehari R, Kurman R J, Logani S, et al. The development of high- gTade serous carcinoma from atypical proliferative (borderline) serous carcinomas and low-grade micmpapillary serous carcinoma: a morpho|ogic and molecular genetic analysis [ J ]. Am J Surg Patho1,2007,31 (7) : 1007 - 1012.
  • 5Kobel M, Kalloger SE, Carrick J, et al. A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary[J]. Am J Surg Pathol, 2009,33(1) : 14 -21.
  • 6Vang R, Shih IeM, Kurman RJ. Ovarian low-grade and high-gTade serous carcinoma: pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems [ J ]. Adv Anal Pathol, 2009,16(5) :267 -282.
  • 7Seidman JD, Kurman RJ. Treatment of micropapillary serous ovarian carcinoma (the aggressive variant of serous borderline tumors) [J]. Cancer, 2002,95(4) :675 -676.

同被引文献77

  • 1胡松建,夏育民,梁虹.皮肤转移癌2例[J].岭南皮肤性病科杂志,2007,14(3):181-182. 被引量:4
  • 2任凤岩,张淑兰,姜彦多,王丹波.卵巢子宫内膜样癌及其合并子宫内膜异位症的临床及病理分析[J].中国实用妇科与产科杂志,2007,23(9):708-709. 被引量:18
  • 3Shih IeM, Kunnan RJ. Ovarian tumorigenesis: a proposed model based on morphological and molecular genetic analysis. Am J Pathol, 2004, 164(5): 1511-1518.
  • 4Karst AM, Drapkin R. Ovarian cancer pathogenesis: a model in evolution. J Oncol, 2010,2010: 932371.
  • 5Gross AL, Kurman RJ, Vang R, et al. Precursor lesions of high- grade serous ovarian carcinoma: morphological and molecular characteristics. J Oncol, 2010, 2010: 126295.
  • 6Vang R1, Kurman RJ, Shih IM. Ovarian Low-grade and high- grade serous carcinoma : pathogenesis, clinicopathologic and molecular biologic features, and diagnostic problems. Adv Anat Pathol, 2009,16(5 ) :267-282.
  • 7Ayhan A, Kurman RJ, Vang R, et al. Defining the cut point between low-grade and high-grade ovarian serous carcinomas: a clinicopathologic and molecular genetic analysis. Am J Surg Pathol, 2009, 33 (8) : 1220-1224.
  • 8Malpica A, Deavers MT, Lu K, et al. Grading ovarian serous carcinoma using a two-tier system. Am J Surg Pathol, 2004, 28 (4) : 496-504.
  • 9Malpica A, Deavers MT, Tornos C, et al. Interobserver and intraobserver variability of a two-tier system for grading ovarian serous carcinoma. Am J Surg Pathol, 2007, 31(8) : 1168-1174.
  • 10Medeiros F, Muto MG, Lee Y, et al. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol, 2006, 30 (2) : 230- 236.

引证文献8

二级引证文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部